🚀 go-pugleaf

RetroBBS NetNews Server

Inspired by RockSolid Light RIP Retro Guy

Article View: be.science
Article #408

Cancer - Press Review (June 30, 2012) – Revue de presse (30 juin 2012)

#408
From: SMW
Date: Sun, 01 Jul 2012 14:29
209 lines
10080 bytes
Cancer – Press Review  – Revue de Presse

Every week on http://marclacroixcancerblog.blogspot.com
Chaque semaine sur http://marclacroixcancerblog.blogspot.com




Press Review (June 30, 2012) – Revue de presse (30 juin 2012)



Women's lung cancer deaths up in South and Midwest‎
Despite falling lung cancer rates across the U.S. in the past decade,
researchers report that deaths from the disease are steady or rising
among middle-aged women in southern and Midwestern states.
By Natasja Sheriff. In Reuters
http://www.reuters.com/article/2012/06/26/us-women-lungcancer-death-idUSBRE85P1H520120626

Side effects persist after prostate cancer treatment‎‎
Men who are treated for prostate cancer may still suffer side effects
from treatment up to a decade later, a new study finds‎.
By Amy Norton. In Reuters
http://www.reuters.com/article/2012/06/27/us-prostratecancer-idUSBRE85Q14320120627

Is it Rationing? Cancer Screening and Clinical Uncertainty‎
Last month, the federal panel that decides which preventive services
health plans must cover said it will drop blood testing for prostate
cancer. The president of the trade group that represents urologists
proclaimed himself and his organization "outraged." He warned that
refusal to cover the test, for levels of prostate-specific antigen
(PSA), will cost lives. And he played the race card, calling it
"inappropriate and irresponsible to issue a blanket statement against
PSA testing, particularly for at-risk populations, such as African-
American men."
By M. Gregg Bloche. In Huffington Post
http://www.huffingtonpost.com/m-gregg-bloche-md-jd/prostate-cancer-screening_b_1622577.html

EU agency backs Novartis' Afinitor in breast cancer
European regulators on Friday recommended approval of a Novartis' for
the treatment of advanced breast cancer.
In Reuters
http://www.reuters.com/article/2012/06/22/us-novartis-afinitor-chmp-idUSBRE85L0K920120622

Glucose deprivation activates feedback loop that kills cancer cells,
UCLA study shows
Compared to normal cells, cancer cells have a prodigious appetite for
glucose, the result of a shift in cell metabolism known as aerobic
glycolysis or the "Warburg effect." Researchers focusing on this
effect as a possible target for cancer therapies have examined how
biochemical signals present in cancer cells regulate the altered
metabolic state.
By Jennifer Marcus. In UC Los Angeles News
http://newsroom.ucla.edu/portal/ucla/researchers-discover-that-glucose-235478.aspx

Moderate exercise tied to lower breast cancer risk: study‎
Women who exercise moderately may be less likely than their inactive
peers to develop breast cancer after menopause, according to a U.S.
study‎.
In Reuters
http://in.reuters.com/article/2012/06/26/health-cancer-exercise-idINL3E8HQ00220120626

What Is Acute Myelogenous Leukemia, the Cancer That Struck Nora
Ephron?
The When Harry Met Sally screenwriter recently succumbed to this
enigmatic form of cancer, but there are new treatments in the
pipeline.
By Larry Greenemeier. In Scientific American
http://www.scientificamerican.com/article.cfm?id=what-is-acute-myelogenous-leukemia

Cutaneous Human Papillomavirus Infection a Risk Factor for Skin Cancer
Researchers at Moffitt Cancer Center and colleagues at the University
of South Florida, the German Cancer Research Center in Heidelberg, and
the International Agency for Research on Cancer in Lyon, France,
conducted a case control study and found associations between having
antibodies to certain types of cutaneous human papillomavirus (HPV)
and a kind of skin cancer called squamous cell carcinoma (SCC).
In Newswise
http://www.newswise.com/articles/cutaneous-human-papillomavirus-infection-a-risk-factor-for-skin-cancer

Study identifies pathway to enhance usefulness of EGFR inhibitors in
lung cancer treatment
Many lung cancers are driven by mutations in the epidermal growth-
factor receptor (EGFR), and so it makes sense that many successful
modern treatments block EGFR activity. Unfortunately, cancers
inevitably evolve around EGFR inhibition, and patients with lung
cancers eventually relapse. A University of Colorado Cancer Center
study published today in the journal Cancer Research details a
signaling pathway, known as 'the canonical Wnt pathway', that lung
cancer cells use to escape from EGFR-targeted therapy – and suggests
that by disrupting this pathway, we could lengthen the usefulness of
existing EGFR inhibition therapies.
In Medical Xpress
http://medicalxpress.com/news/2012-06-pathway-egfr-inhibitors-lung-cancer.html

Metformin may lower cancer risk in people with Type 2 diabetes‎
‎A commonly prescribed diabetes drug, metformin, reduces the overall
cancer risk in people with Type 2 diabetes, a large systematic review
study finds. The results to be presented at The Endocrine Society's
94th Annual Meeting in Houston.
In Medical Xpress
http://medicalxpress.com/news/2012-06-metformin-cancer-people-diabetes.html


Les "perles" du cancer‎‎
"T'as acheté bio, ton cancer aussi sera bio. Et, pour la chimio, je te
conseille la coccinelle." Cette réplique de Not, le "punk à chien"
interprété par Benoît Poelvoorde dans le film Le Grand Soir de Bruno
Delépine et Gustave Kerven, m'a fait rire aux éclats et ne me quitte
pas. Assis sur le bitume d'un parking de centre commercial, Not
interpelle ainsi un couple qui pousse son chariot rempli de produits
biologiques. L'histoire ne dit pas si ces consommateurs repartent
ensuite en voiture diesel "qui pue et qui pollue" et se grillent une
cigarette en arrivant chez eux pour décompresser de leur samedi passé
à faire les courses. Le soir, ils se rassureront sur leur hygiène de
vie en mangeant du bio.
Par Sandrine Blanchard. Dans Le Monde
http://www.lemonde.fr/idees/article/2012/06/27/les-perles-du-cancer_1725219_3232.html

Diagnostiquer un cancer à partir d'une prise de sang‎
Une équipe française de médecins biologistes travaillant à l’Institut
Curie de Paris vient de mettre au point  une technique permettant de
détecter de l’ADN d’une tumeur cancéreuse dans le sang du malade. Ce
procédé simple, reproductible et peu coûteux pourrait à terme
s’appliquer à tous les cancers pour lesquels une mutation génétique a
d’ores et déjà été identifiée.
Dans Slate
http://www.slate.fr/lien/58387/cancer-sang-diagnostic

Cancer: un essai pour tenter de généraliser les traitements
personnalisés
L'Institut Gustave Roussy (IGR) a annoncé jeudi le lancement d'un
essai clinique international pour proposer des traitements
personnalisés à des patients qui, jusqu'à présent, ne pouvaient
bénéficier que de traitements standards.
"L'objectif de cet essai est de proposer un traitement personnalisé à
la très grande majorité des patients" alors qu'actuellement seulement
30% des patients peuvent en bénéficier, indique dans un communiqué
l'IGR, établissement privé situé en région parisienne qui se présente
comme "premier centre de lutte contre le cancer en Europe".
AFP
http://www.google.com/hostednews/afp/article/ALeqM5iwUGcNNPftltYzWafIzTHBqxEW5Q?docId=CNG.f2cb774c36314f054aed4b0fc22873fc.321

Traiter le cancer comme une maladie chronique‎
De nouvelles recherches pourraient conduire ainsi Ă  des traitements
permettant de faire passer le cancer d'une maladie mortelle Ă  une
maladie chronique.
Dans bulletins-electroniques.com
http://www.bulletins-electroniques.com/actualites/70402.htm

Hausse des cancers chez les jeunes Algériens
Les adolescents et jeunes adultes âgés entre 15 et 39 ans sont de plus
en plus affectés par le cancer. Le cancer du sein touche 30% de cette
population. La consanguinité, l’alimentation et l’environnement sont
les facteurs les plus incriminés.
Dans El Watan
http://www.elwatan.com/une/hausse-des-cancers-chez-les-jeunes-algeriens-24-06-2012-175962_108.php









Cancer Blog – Marc Lacroix – Le Blogue du Cancer
http://marclacroixcancerblog.blogspot.com










Marc Lacroix-Corman – InTextoResearch – Baelen  (06/2012)
Technical Details
Message-ID: <e5156e56-33da-423b-8ce0-dc2252826e15@q29g2000vby.googlegroups.com>
Path: arc1-ca.pugleaf.net!l9ni6370pbj.0!nntp.google.com!news2.google.com!postnews.google.com!q29g2000vby.googlegroups.com!not-for-mail

Show Full Headers
Complete Article Headers
X-Google-Thread: f5500,f67b550ea70fc9ce,start
X-Google-NewGroupId: yes
X-Google-Attributes: gida254ea4a8d,domainid0,public,usenet
X-Google-Language: ENGLISH,UTF8
Received: by 10.68.227.67 with SMTP id ry3mr8003230pbc.8.1341154636187;
        Sun, 01 Jul 2012 07:57:16 -0700 (PDT)
Path: arc1-ca.pugleaf.net!l9ni6370pbj.0!nntp.google.com!news2.google.com!postnews.google.com!q29g2000vby.googlegroups.com!not-for-mail
From: SMW <scimedweb@mail.com>
Newsgroups: be.science
Subject: Cancer - Press Review (June 30, 2012) – Revue de presse (30 juin 2012)
Date: Sun, 1 Jul 2012 07:29:37 -0700 (PDT)
Organization: http://groups.google.com
Lines: 209
Message-ID: <e5156e56-33da-423b-8ce0-dc2252826e15@q29g2000vby.googlegroups.com>
NNTP-Posting-Host: 81.247.76.16
Mime-Version: 1.0
X-Trace: posting.google.com 1341154636 5552 127.0.0.1 (1 Jul 2012 14:57:16 GMT)
X-Complaints-To: groups-abuse@google.com
NNTP-Posting-Date: Sun, 1 Jul 2012 14:57:16 +0000 (UTC)
Complaints-To: groups-abuse@google.com
Injection-Info: q29g2000vby.googlegroups.com; posting-host=81.247.76.16; posting-account=jR3pwAkAAABfF7uqn-zMzWqez-yhPWKE
User-Agent: G2/1.0
X-HTTP-UserAgent: Opera/9.80 (Windows NT 5.1; U; fr) Presto/2.10.289 Version/12.00,gzip(gfe)
Content-Type: text/plain; charset=UTF-8
Content-Transfer-Encoding: quoted-printable